Clinical Ink: new executive appointments
The clinical trial tech firm has appointed three people to new positions, reportedly created to help the company manage demand for its eCOA, ePRO+, DDC, and eConsent platform.
The three new hires are:
- Chris Crucitti, chief commercial officer, a life sciences and clinical services/technology executive with more than 20 years of experience
- Brian Donahue, chief operating officer, who held a number of leadership roles at GE before joining Clinical Ink
- Bill Barrasso, vice president of project operations, who comes to the company from Paraxel
